Asthma Severe Persistent Controlled

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Asthma Severe Persistent Controlled trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07342803

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

This is a multicenter, randomized, masked, active and placebo controlled, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetics of LP-0…

China200 participantsStarted 2025-01-25

Treatment: LP-003 Injection, Omalizumab

All recent trials (41 shown)

Active — Not RecruitingPhase 2

NCT05064631

Bacterial Lysate In Preventing Asthma

Bronchiolitis is a common viral infection of the small airways of infants and some affected infants will require hospital admission. Severe bronchiolitis is a m…

United Kingdom173 participantsStarted 2022-01-12

Treatment: Bacterial Lysate

CompletedPhase 2

NCT04773678

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

This study will evaluate the efficacy, safety of two dose levels of CBP-201 in patients with moderate to severe persistent asthma with Type 2 inflammation.

United States322 participantsStarted 2021-05-11

Treatment: CBP-201, Placebo

Asthma Severe Persistent Controlled

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

All recent trials (41 shown)

Bacterial Lysate In Preventing Asthma

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

All recent trials (41 shown)

Bacterial Lysate In Preventing Asthma

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Phase I Clinical Trial of TQC2731 Injection

Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

Dose Finding Study for QAW039 in Asthma

Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels

Inhaled Steroids and Control of Severe Asthma

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma

Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Pu…

Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment…

Study to Evaluate the Safety and Efficacy of CAT-354

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma